These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6477682)

  • 1. Anti-tumor effect of a streptococcal preparation (OK-432). 1. Positive co-relation between the anti-tumour effect and delayed type hypersensitivity reaction to OK-432 in mice.
    Makidono R; Matsuura K; Makidono A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Feb; 44(2):379-91. PubMed ID: 6477682
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of streptococcal preparation, OK-432, on experimental infection due to Mycobacterium lepraemurium in mice of C3H/Jms strain.
    Saito H; Tomioka H; Sato K
    Hiroshima J Med Sci; 1983 Jun; 32(2):231-4. PubMed ID: 6352569
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between anti-tumor effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings].
    Kokunai I; Mori T; Yayoi E; Matuura N; Kosaki G
    Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):258-65. PubMed ID: 3982380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the hepatoma cell injury by antibody-dependent cell-mediated cytotoxicity and its augmentation by pretreatment of macrophages with OK432].
    Mizoguchi Y; Tsutsui H; Yamamoto S; Morisawa S
    Arerugi; 1984 Mar; 33(3):135-41. PubMed ID: 6466102
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a streptococcal preparation, OK-432, on murine hematopoietic stem cells.
    Hiraoka A; Yamagishi M; Ohkubo T; Yoshida Y; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):860-3. PubMed ID: 6977253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differences in the immunostimulatory activity and antitumor therapeutic effect of OK-432 and N-CWS].
    Mizushima Y; Iwata M; Sato M; Hirata H; Takashima A; Yano S
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2404-10. PubMed ID: 3729493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction and measurement of delayed hypersensitivity to OK-432].
    Kohunai I; Mori T; Yayoi E; Kosaki G
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1387-92. PubMed ID: 6521720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells.
    Ozaki S; Suginoshita T; Watanabe T; Obayashi H
    Cancer Res; 1990 Aug; 50(15):4630-4. PubMed ID: 2369739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effect of murine peritoneal exudate cells activated with a streptococcal preparation, OK-432, on hematopoietic stem cells.
    Hiraoka A; Yamagishi M; Ohkubo T; Yoshida Y; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):82-90. PubMed ID: 6981281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1479-89. PubMed ID: 6521727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice.
    Satoh M; Shimada Y; Inagawa H; Minagawa H; Kajikawa T; Oshima H; Abe S; Yamazaki M; Mizuno D
    Jpn J Cancer Res; 1986 Apr; 77(4):342-4. PubMed ID: 2422147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of streptococcal preparation OK-432 on chemically-induced intestinal carcinoma in rats.
    Ichihashi H; Kuzuya H; Kondo T
    Nagoya J Med Sci; 1980 Mar; 42(3-4):49-54. PubMed ID: 7383144
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy of murine tumors with lentinan, bacterial lipopolysaccharide and a Streptococcus preparation, OK432.
    Abe S; Takahashi K; Tsubouchi J; Yamazaki M; Mizuno D
    Gan; 1983 Apr; 74(2):273-8. PubMed ID: 6862148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between enhancement of natural killer (NK) activity by an immunopotentiator (OK-432) and resistance to human hepatoma cell implantation in nude mice].
    Saito H; Morizane T; Kumagai N; Inagaki Y; Nakamura T; Satoh I; Iino A; Matsumura S; Kawamura N; Tsuchiya M
    Nihon Shokakibyo Gakkai Zasshi; 1985 Dec; 82(12):2923-9. PubMed ID: 3831444
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
    J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological response modifier OK-432 (a streptococcal preparation) inhibits the development of autoimmune kidney disease in NZB/W F1 hybrid mice: possible involvement of tumor necrosis factor.
    Mihara M; Ohsugi Y
    Int Arch Allergy Appl Immunol; 1989; 90(1):37-42. PubMed ID: 2807578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.